Literature DB >> 27530891

Rainbow of hemolysis associated with acquired thrombotic thrombocytopenic purpura.

Jay S Raval1, Marshall A Mazepa1, Daniel B Kim-Shapiro2, Swati Basu2, Raj S Kasthuri3, Herbert C Whinna1, Yara A Park1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27530891      PMCID: PMC5746043          DOI: 10.1002/jca.21487

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


× No keyword cloud information.
  5 in total

Review 1.  The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Authors:  Russell P Rother; Leonard Bell; Peter Hillmen; Mark T Gladwin
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

Review 2.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

Review 3.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 4.  Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.

Authors:  Dominik J Schaer; Francesca Vinchi; Giada Ingoglia; Emanuela Tolosano; Paul W Buehler
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

Review 5.  The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS.

Authors:  David R Janz; Lorraine B Ware
Journal:  J Intensive Care       Date:  2015-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.